Company profile
National Research Corporation
NASDAQ: NRC · Healthcare · Medical - Healthcare Information Services
#320 of 1,417 Healthcare companies by revenue35th-percentile growth
EA Score
75B+FH 80DQ 78GM 54SS 71
v0.1 · 65/100 weight · provisional
↑ return on equity, return on assets · ↓ balance-sheet leverage, revenue growth (YoY)
Methodology →Revenue TTM
$138.6M
Rev growth YoY (TTM)
-1.9%
Net income (FY)
$11.6M
Employees
357
as of 2026-08-12
Market cap
$481.8M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$137.4M$137.4M2025
Net income$11.6M$11.6M2025
Operating income$22.6M$22.6M2025
Total assets$134.9M$134.9M2025
Liabilities$120.9M$120.9M2025
Equity$14.0M$14.0M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is National Research Corporation’s revenue?
National Research Corporation booked $137.4M in FY2025 revenue, contracting 4.0% year over year — slower than 65% of Healthcare companies we track, at a 8.4% net margin.
Peers · Healthcare
Spok Holdings, Inc.83B+Quanterix Corporation56CTelesis Bio, Inc.——RxSight, Inc.59CXtant Medical Holdings, Inc.74BUpHealth, Inc.——Key facts
CEOTrent Green
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersLincoln, NE
ExchangeNASDAQ: NRC
Employees357
IPO date2013-05-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.